Edition:
United States

Unilife Corp (UNSta.AX)

UNSta.AX on Australia Stock Exchange

--AUD
19 Jan 2017
Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
--
52-wk Low
--

Summary

Name Age Since Current Position

Mary Wold

63 2016 Non-Executive Chairman of the Board, Lead Independent Director

John Ryan

47 2016 President, Chief Executive Officer, Director

David Hastings

55 2016 Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer

Ian Hanson

43 2016 Chief Operating Officer, Senior Vice President

Stephanie Walters

39 2016 Senior Vice President, General Counsel, Secretary

Michael Ratigan

48 2016 Senior Vice President and Chief Commercial Officer

Molly Weaver

36 2016 Chief Compliance Officer, Vice President - Quality and Regulatory Affairs

Rosemary Crane

57 2016 Director

Duane DeSisto

62 2016 Director

Jeff Carter

58 2009 Non-Executive Director

Harry Hamill

62 2015 Independent Director

Michael Kamarck

65 2016 Independent Director

John Lund

50 2009 Independent Non-Executive Director

Biographies

Name Description

Mary Wold

Ms. Mary (Kate) Katherine Wold is Non-Executive Chairman of the Board, Lead Independent Director of the company. Ms. Wold has served as our director since May 2010. She served as our lead independent director from August 2015 to March 2016, and has served as our Chair since March 2016. From August 2015 until her appointment as Chair, Ms. Wold served as our Vice Chair. Since 2011, Ms. Wold has served as Chief Executive Officer of the Church Pension Fund, which oversees defined benefit and defined contribution pension plans for clergy and lay employees of the Episcopal Church. Prior to her position at the Church Pension Fund, Ms. Wold served as Senior Vice President of Finance from 2007 to 2009, Senior Vice President of Tax and Treasury from 2005 to 2007 and Vice President of Tax from 2002 to 2005, of Wyeth, a NYSE-listed pharmaceutical company, which was acquired by Pfizer in October 2009. Prior thereto, Ms. Wold spent 17 years with the international law firm of Shearman & Sterling based in New York, specializing in international tax planning for multinational corporations and in the tax aspects of mergers and acquisitions, capital markets and private equity transactions. Ms. Wold received her law degree from the University of Michigan and her Bachelor of Arts degree from Hamline University.

John Ryan

Mr. John C. Ryan, J.D. is President, Chief Executive Officer, Director of the Company. Mr. Ryan has served as our President and Chief Executive Officer and as our director since July 2016. Mr. Ryan served as our Interim President and Chief Executive Officer from March 2016 until July 2016, and as our Senior Vice President, General Counsel and Secretary from May 2014 until July 2016. Mr. Ryan served as a Partner at Duane Morris LLP from 2013 to 2014. From 2012 to 2013, Mr. Ryan served as Senior Vice President and Deputy General Counsel of Aramark Corporation, and from 2005 to 2012, as its Senior Vice President and Associate General Counsel. From 1999 to 2005, Mr. Ryan served first as an Associate and then as a Partner at Duane Morris LLP. From 1995 to 1999, Mr. Ryan served as an Assistant District Attorney at the New York County District Attorney’s Office. Mr. Ryan received a J.D. from Northwestern University School of Law and a B.A. from New York University. Mr. Ryan is a member in good standing of the bars of Pennsylvania and New York. As our President and Chief Executive Officer, Mr. Ryan provides critical contributions to the Board through his detailed knowledge of our Company, employees, products, customers, investors and the strategic marketplace.

David Hastings

Mr. David Hastings is Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer of the Company. He has served as our Senior Vice President and Chief Financial Officer since February 2015. Prior to joining Unilife, Mr. Hastings served as Executive Vice President and Chief Financial Officer of Incyte Corporation, a pharmaceutical company, from 2003 through 2014. From February 2000 to September 2003, Mr. Hastings served as Vice President, Chief Financial Officer, and Treasurer of ArQule, Inc., or ArQule. Prior to his employment with ArQule, Mr. Hastings was Vice President and Corporate Controller at Genzyme, Inc., or Genzyme, where he was responsible for the management of the finance department. Prior to his employment with Genzyme, Mr. Hastings was the Director of Finance at Sepracor, Inc. (now known as Sunovion Pharmaceuticals, Inc.), or Sepracor, a pharmaceutical company, where he was primarily responsible for Sepracor’s internal and external reporting. Mr. Hastings received his B.A. in Economics at the University of Vermont.

Ian Hanson

Mr. Ian Hanson is Chief Operating Officer, Senior Vice President of the company. Mr. Hanson has served as our Senior Vice President and Chief Operating Officer since July 2016 and has served as our Senior Vice President and General Manager, Advanced Drug Delivery Systems since November 2014. From October 2012 to November 2014, Mr. Hanson served as our Vice President and General Manager, Advanced Drug Delivery Systems, and from July 2011 until October 2012, Mr. Hanson served as our Director, Advanced Drug Delivery Systems. Prior to joining Unilife, Mr. Hanson served in the roles of Senior Engineering Manager, Manager, and Lead of Advanced Engineering & Systems Department of Medtronic Diabetes during the period from March 2003 to July 2011. From May 2000 to March 2003, Mr. Hanson held various engineering roles in external mechanical research and development for Medtronic Diabetes. Prior to that, Mr. Hanson served as Chief Engineer for Inca One Corporation. Mr. Hanson holds a Bachelor’s degree of Mechanical Engineering from California Polytechnic State University and a Master’s degree in Mechanical Engineering from the University of California at Los Angeles.

Stephanie Walters

Ms. Stephanie Walters is Senior Vice President, General Counsel, Secretary of the Company. Ms. Walters has served as our Senior Vice President, General Counsel and Secretary since July 2016 and, from July 2014 until her recent appointments in July 2016, served as our Associate General Counsel and Assistant Secretary. Prior to joining the Company, from January 2010 to July 2014, Mr. Walters served as an Assistant General Counsel at Aramark Corporation. Ms. Walters served as an Associate at Pepper Hamilton LLP from September 2005 to January 2010. Prior to law school, Ms. Walters served as a Legislative Assistant on the U.S. Senate Judiciary Committee. Ms. Walters received a J.D. from Temple University, Beasley School of Law, and an A.B. with honors from Harvard College. Ms. Walters is a member in good standing of the bar of Pennsylvania.

Michael Ratigan

Mr. Michael C. Ratigan is Senior Vice President and Chief Commercial Officer of the Company. Mr. Ratigan has served as our Senior Vice President and Chief Commercial Officer since August 2012 and as our Vice President, Commercial Development from April 2011 until August 2012. Prior to joining Unilife, he served as the Commercial Development Director for Self-Administration of Injectable Systems (SAIS) at Becton Dickinson. Prior to this, he also held the additional role of Director of Sales (Prefilled Syringes) for North America, where he led the prefilled syringe commercial organization responsible for sales, customer service and commercial development. Mr. Ratigan was a member of the Strategic Marketing Team and served as Group Product Manager at Stryker Orthopedics where he was responsible for business planning, marketing, commercial product launch and sales support for multiple product lines. Mr. Ratigan holds a B.S. degree in Marketing from Boston College.

Molly Weaver

Dr. Molly Weaver, Ph.D. is Chief Compliance Officer, Vice President - Quality and Regulatory Affairs of the Company. Dr. Weaver has served as our Vice President, Corporate Quality and Regulatory Affairs and Chief Compliance Officer since July 2016. She joined Unilife in 2011, initially serving as a Manager, Advanced Drug Delivery Systems. She also held roles as Director and as Vice President and General Manager, Advanced Drug Delivery Systems. Prior to joining Unilife, she was a Core Team Leader, Self-Injection, with Becton Dickinson Pharmaceutical Systems where she was responsible for a portfolio of existing technologies and future customizations for a range of commercial and clinical phase pharmaceutical partners. Dr. Weaver holds a Ph.D. in Mechanical Engineering and Materials Science from Duke University, and a Sc.B. in Biomechanical Engineering from Brown University.

Rosemary Crane

Ms. Rosemary A. Crane is the Director of the Company. Ms. Crane has previously served as President and Chief Executive Officer of Epocrates, Inc., and prior to leading Epocrates, she held senior executive positions at Johnson & Johnson, including Group Chairman, OTC & Nutritional Group, Group Chairman, Consumer, Specialty Pharmaceuticals and Nutritionals, and Executive Vice President of Global Marketing for the Pharmaceutical Group. Ms. Crane has also served in executive roles at Bristol-Myers Squibb, including President of U.S. Primary Care and President of Global Marketing and Consumer Products. She presently serves as a Director of Teva Pharmaceuticals and as Vice Chairman of the Board of Zealand Pharma A/S. Ms. Crane received her MBA from Kent State University and her BA in Communications and English from the State University of New York.

Duane DeSisto

Mr. Duane M. DeSisto is the Director of the Company. Mr. DeSisto served as the President and Chief Executive Officer of Insulet Corporation from 2003 to 2014, after serving as Insulet’s Acting Chief Executive Officer and Chief Financial Officer and Treasurer. Prior to his executive roles at Insulet, Mr. DeSisto was President, Chief Executive Officer and Chief Financial Officer of PaperExchange.com, Inc., Chief Financial Officer of FGX International Holdings Limited (formerly AAI-Foster Grant, Inc.), and Chief Financial Officer of ZOLL Medical Corporation. Mr. DeSisto earned a Bachelor of Science from Providence College and a Masters of Business Administration from Byrant College.

Jeff Carter

Mr. Jeff Carter serves as an Non-Executive Director of the company. Mr. Carter has served as our director since April 2006. From March 2007 to July 2010, Mr. Carter served as company Secretary for UMSL. From February 2005 until January 2009, Mr. Carter served as Chief Financial Officer of UMSL. Mr. Carter was a Chief Financial Officer of various publicly listed healthcare companies prior to joining UMSL in February 2005 and is currently Chief Financial Officer of Innate Immunotherapeutics, an ASX listed public company. Prior to entering the healthcare industry, Mr. Carter held senior management positions with Coca Cola Amatil, Santos Ltd., Canadian Imperial Bank of Commerce and Touche Ross (now known as Deloitte Touche Tohmatsu). Mr. Carter has in excess of 30 years of experience in professional accounting, investment banking, corporate finance and commercial/strategic planning roles. Mr. Carter is a Chartered Accountant and holds a Master’s Degree in Applied Finance from Macquarie University and a Bachelor of Financial Administration from New England University.

Harry Hamill

Mr. Harry Hamill is an Independent Director of the Company. Mr. Hamill has served as our director since August 2015. Mr. Hamill has served as an advisor in the life sciences industry since 2010. From 2008 to 2010, Mr. Hamill served as Vice President and Deputy Controller of Wyeth, and held other senior positions at Wyeth from 1992 to 2008, including leading global mergers and acquisitions, Vice-President of Finance for Wyeth’s Global Manufacturing and Distribution Operations, and Chief Financial Officer of a global animal health business unit. Wyeth was acquired by Pfizer in October 2009. Prior to his career at Wyeth, Mr. Hamill was a Partner with Parente Randolph Orlando Carey and Associates, a regional U.S. accounting firm. Prior to that, Mr. Hamill was a Senior Audit Manager with Arthur Andersen LLP in New York. He is a certified public accountant and a graduate of Bernard M. Baruch College, City University of New York.

Michael Kamarck

Dr. Michael E. Kamarck, Ph.D. is Director of the Company. From 2009 to 2012, Dr. Kamarck served as President of Merck BioVentures and Senior Vice President of Vaccines and Biologics Manufacturing for Merck. From 2001 to 2009, he held various senior executive positions at Wyeth, including President, Technical Operations and Product Supply and was responsible for global technical operations for all of Wyeth’s businesses. Dr. Kamarck also served as a member of the Wyeth Management Committee. Prior to Wyeth, he was employed by Bayer AG for 17 years in a variety of technical and leadership capacities. Dr. Kamarck received his B.A. from Oberlin College and his Ph.D. from the Massachusetts Institute of Technology in Biochemistry, and he was a Leukemia Society Fellow at Yale University.

John Lund

Mr. John M. Lund serves as an Independent Non-Executive Director of the company. Mr. Lund has served as our director since November 2009. Since October 2016, Mr. Lund has served as Chief Financial Officer for Behavioral Health Group, a private equity backed leading provider of opioid addiction treatment services. From February 2012 to December 2015, Mr. Lund served as Chief Financial Officer of Reliant Rehabilitation, a private equity backed company, which is a provider of long-term care rehabilitation services with over 7,000 U.S. based employees. Mr. Lund has also served as a Managing Partner of Upstart CFO, LLC, a financial consulting company providing chief financial officer advisory services, since December 2010, and M&A Holdings, LLC, a private consulting company, since July 2003. Prior to that, Mr. Lund held chief financial officer and controller positions for various public and private companies, and was a manager at KPMG LLP, or KPMG. Mr. Lund received the Certificate of Director Education from the National Association of Corporate Directors, or NACD, and completed various corporate governance courses at Harvard Business School. Mr. Lund, a certified public accountant, graduated from University of North Texas and received his Master of Business Administration from the Kellogg School of Management of Northwestern University. Mr. Lund is actively involved in the NACD, Financial Executive Institute, American Institute of Certified Public Accountants and the Texas Society of Certified Public Accountants.

Basic Compensation